je.st
news
Tag: pfizer
Merck Enters Strategic Collaborations with Amgen, Incyte and Pfizer to Evaluate Novel Combination Anti-cancer Regimens with MK-3475
2014-02-05 12:40:00| Merck.com - Research & Development News
Dateline City: WHITEHOUSE STATION, N.J. Merck Also to Initiate Phase I Signal Finding Study with MK-3475 in 20 New Cancer Types WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, announced today it has signed three separate clinical collaboration agreements, through subsidiaries, with Amgen Inc., Incyte Corporation and Pfizer Inc. to evaluate novel combination regimens with MK-3475, Mercks investigational anti-PD-1 immunotherapy. The financial terms of the agreements were not disclosed. Language: English Contact: MerckMedia:Ian McConnell, 908-423-3046orClaire Mulhearn, 908-423-7425orInvestors:Carol Ferguson, 908-423-4465orJustin Holko, 908-423-5088 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: with
combination
strategic
evaluate
Pfizer Focuses on Experimental Drugs to Regain Revenue Losses
2014-02-02 20:33:41| Biotech - Topix.net
Pfizer Inc. is expecting results on two different clinical trials of treatment, which it hopes will help the company make up for the billions of dollars it lost in revenue in the past few years.
Tags: experimental
drugs
revenue
losses
Stocks open higher on Wall Street; Pfizer gains
2014-01-28 19:05:57| Biotech - Topix.net
Even though we've entered the early hours of 2014, let's cast our minds back to the year that just... NEW YORK - Stocks are higher in early trading on Wall Street as the stock market turns positive after three days of losses.
Pfizer says lung cancer drug fails two late-stage studies
2014-01-27 15:48:33| Biotech - Topix.net
Pfizer Inc said its experimental lung cancer drug failed to meet its goals in two late-stage studies in patients with advanced non-small cell lung cancer.
Tags: studies
drug
cancer
fails
Mylan gets rights to Pfizer compound
2014-01-07 02:00:19| Biotech - Topix.net
Mylan Inc. has purchased the rights to a novel respiratory compound from New York City-based Pfizer Inc., which will be developed into combination therapies used in the treatment of breathing problems.
Tags: rights
compound
pfizer
mylan
Sites : [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] next »